Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06KCF
|
|||
| Former ID |
DCL001207
|
|||
| Drug Name |
Mavrilimumab
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 2 | [1], [2] | |
| Company |
MedImmune
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7785). | |||
| REF 2 | Clinical pipeline report, company report or official report of MedImmune (2011). | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.